The closing plenary session at ANA2022 spotlighted neurologic health inequities and presented new research finding that neighborhood disadvantage strongly predicted likelihood of death from neurologic conditions independent of individual wealth and demographics.
Desde la enfermedad de Alzheimer y el asma hasta la diabetes y los medicamentos para quimioterapia, los investigadores de Mayo Clinic están utilizando el banco biológico Sangre Por Salud Biobank en Arizona, el cual es una fuente abundante de especímenes biológicos que amplía la diversidad en la investigación médica.
Ochsner Health psychologist discusses Alzheimer's Disease during Alzheimer's Awareness Month
Alzheimer's disease is a risk factor for epilepsy - and epilepsy is a risk factor for Alzheimer's. We spoke with Dr. Andrew Cole and Dr. Alice Lam about the latest research and some intriguing findings that suggest links between these two conditions.
Sex differences in the aging brain may offer an enticing clue for researching more effective neuroprotective treatments, according to a new treatment development strategy laid out by UCLA researchers.
CLEVELAND - Considering how patients from different ethnic groups respond to the same drug could be crucial to finding new Alzheimer’s disease treatments – a disorder the Alzheimer’s Association previously deemed a “silent epidemic” among Black adults. A Cleveland Clinic-led study published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association showed that telmisartan, a drug currently prescribed for people with high blood pressure, is associated with a lower risk of Alzheimer’s specifically in Black patients over age 60. Insurance data from millions of adults over age 60 did not show the same potential effect in white patients.
In an analysis of data from the Framingham Heart Study, albuminuria (a marker of kidney disease) was associated with signs of silent stroke, and patients with albuminuria had a higher risk of developing mild cognitive impairment or dementia.
Accumulating evidence finds that exercise can improve brain function and delay or prevent the onset of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
مدينة روتشستر، ولاية مينيسوتا -- تزداد مخاطر الإصابة بالخرف والسرطان وأمراض الأوعية الدموية مع التقدم في العمر، وكذا يزداد عدد سكان الولايات المتحدة من كبار السن. لكن العلاقة بين تلك الحالات المرضية ما تزال غير مفهومة بالكامل. في الآونة الأخيرة، أعلن باحثو مايو كلينك عن اكتشاف مثير للاهتمام مفاده: أن وجود تاريخ من الإصابة بالسرطان أو مرض الشريان التاجي قد يقلل من خطر الإصابة بالخرف. ونُشرت نتائج دراستهم في مجلة مرض الزهايمر.
Os riscos de demência, câncer e doença arterial coronariana aumentam com o avanço da idade, e a população dos Estados Unidos está envelhecendo. Mas, até então, a conexão entre as condições não estava plenamente compreendida. Agora, os pesquisadores da Mayo Clinic relatam uma descoberta intrigante: ter histórico de câncer ou doença arterial coronariana pode reduzir o risco de demência. Os resultados do estudo foram publicados na revista médica Journal of Alzheimer's Disease.
Los riesgos de padecer demencia, cáncer y enfermedades vasculares aumentan con la edad, y la población de los EE. UU. está envejeciendo. Sin embargo, no se comprende plenamente la conexión entre las afecciones. Ahora, los investigadores de Mayo Clinic informan un hallazgo interesante: tener antecedentes de cáncer o enfermedad de las arterias coronarias puede reducir el riesgo de padecer demencia. Los resultados del estudio están publicados en la revista Journal of Alzheimer's Disease.
More than half of people over 50 say they’ve helped at least one person over 65 take care of their health, personal hygiene, home or finances in the past two years. Nearly all say they get something positive out of the experience.
Drug companies and university-based teams are working urgently to find and test new medications that could prevent or slow the decline of brain function in older adults. But a new study suggests they’ll need to work harder to find volunteers for their clinical trials.
Donna Wilcock, Ph.D., of the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs — aducanumab and lecanemab — which have been shown to slow the progression of cognitive decline.
The Alzheimer's Clinical Trial Consortium (ACTC) will be presenting analyses of screening plasma and neuroimaging data from the AHEAD Study at CTAD in November.
Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease.
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Physicists at McMaster University have identified a natural delivery system which can safely carry potent antibiotics throughout the body to selectively attack and kill bacteria by using red blood cells as a vehicle.
A new study sheds light on the basic biology of frontotemporal dementia caused by a particular genetic mutation
As a stand-up comedian, Debra Faulk is an expert at transforming the most difficult and uncomfortable moments of her life into something that lifts others. Active in the local comedy scene, the 54-year-old Lexington native uses standup as a platform to shine a light on serious health issues, with much of her routine inspired by her family’s experiences: one sister dealt with intellectual disabilities while another had breast cancer, her brother served in Desert Storm and came back with PTSD, her father had dementia, and her mother was on dialysis.
Johns Hopkins Medicine researchers say they have successfully used a cell’s natural process for making proteins to “slide” genetic instructions into a cell and produce critical proteins missing from those cells.
New research will aim to identify the electrical activity occurring as the brain receives information and then test whether targeted, gentle electrical stimulation can strengthen a specific memory.
Cecilia Lindestam Arlehamn, Ph.D., aims to shed light on how sex-based immune system differences may affect the development and progression of these neurodegenerative diseases in men versus women.
Higher exposure to a certain type of traffic-related air pollution called particulate matter may be linked to an increased risk of dementia, according to a meta-analysis published in the October 26, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. Researchers specifically looked at fine particulate matter, PM2.5, which consists of pollutant particles of less than 2.5 microns in diameter suspended in air. The meta-analysis included all available studies on air pollution and risk of dementia.
Here are some of the latest articles that have been added to the Drugs and drug abuse channel.
A global study of over 28,000 people has provided the strongest evidence to date that lowering blood pressure in later life can cut the risk of dementia.
The Presidential Symposium at the ongoing American Neurological Association 147th Annual Meeting outlined major risks to neurological health from environmental exposures to pesticides, air pollution, synthetic materials, and more — now emerging as a major research area in neuroscience.
As the American Neurological Association’s 147th Annual Meeting wraps up today, October 25, the ANA is holding a Media Roundtable at 11 a.m. U.S. Central for reporters to access the latest developments in neurology and neuroscience.
The cognitive decline and memory loss observed in Alzheimer’s disease (AD) is attributed to the accumulation of β-amyloid protein (Aβ), which impairs neural function in the brain.
The American Neurological Association (ANA), the professional organization representing the world’s leading academic neurologists and neuroscientists, has appointed Brenda Orffer, CAE, as its new Chief Executive Officer and Nadine Goldberg, PhD, MS, as Chief Program Officer.
The latest articles that have been added to the Environmental Health channel.
Together with colleagues from Innopolis University, scientists from Immanuel Kant Baltic Federal University used machine learning methods to study the changing connection and coordination of different parts of the brain with age.
Alzheimer’s disease (AD) currently has no cure and is predicted to affect over 100 million people worldwide by 2050. Ongoing research is focused on two key neurotoxic proteins: amyloid beta (Aβ) and tau.
Depression has long been associated with an increased risk of dementia, and now a new study provides evidence that timely treatment of depression could lower the risk of dementia in specific groups of patients.
The Presidential Symposium at the American Neurological Association’s 2022 Annual Meeting (ANA2022) in Chicago will shine a spotlight on the role of environmental exposures — air pollution, pesticides, microplastics, and more — in diseases like dementias and developmental disorders.
Abstracts of breaking research in neurology and neuroscience, to be presented at the 2022 American Neurological Association Annual Meeting Oct. 22-25, are now available in Annals of Neurology and on the ANA2022 website.
People living with dementia may benefit from talking therapies available on the NHS, if they suffer from anxiety or depression, finds a new study led by UCL researchers.
Scientists at St. Jude Children’s Research Hospital created a model to study the role of RNA splicing defects in Alzheimer’s disease, revealing degeneration and toxicity caused by neuron hyperexcitability.
“Women are better. The female advantage is consistent across time and life span, but it is also relatively small”, says Marco Hirnstein, professor at The University of Bergen, Norway.
Thirty initiatives were supported by Penn Medicine CAREs grants this past quarter, along with programs to provide caregiver respite and encourage STEM education.
New findings by the American Cancer Society showed disparities in mortality rates by educational attainment as a measure of socio-economic status considerably increased in 2020 compared to prior years.
Women who experience more hot flashes and night sweats during menopause may have more of a brain biomarker called white matter hyperintensities, according to a new study published in the October 12, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A number of studies have suggested that eating a healthy diet may reduce a person’s risk of dementia, but a new study has found that two diets including the Mediterranean diet are not linked to a reduced risk of dementia. The study is published in the October 12, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Researchers at the University of Miami Miller School of Medicine collaborated on a recently published paper that provides new guidance on inclusion of underrepresented populations in genetics research.
In a long-term prospective study of more than 600 older participants, Johns Hopkins Medicine researchers say they have evidence that higher levels of cell-free DNA circulating in the blood may signal increased risk of chronic inflammation associated with early signs of frailty and dementia.
Researchers from Hokkaido University and Toppan have developed a method to detect build-up of amyloid β in the brain, a characteristic of Alzheimer’s disease, from biomarkers in blood samples.
The American College of Surgeons (ACS) is the recipient of a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to develop comprehensive educational resources to improve surgical care and outcomes for older adults with Alzheimer’s disease and related dementias who are undergoing surgery.
People with psychotic disorders such as schizophrenia are 2.5 times more likely than those without a psychotic disorder to eventually develop dementia, according to a review of evidence led by UCL researchers.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
